NCT01950351View on ClinicalTrials.gov

Hypofractionated Proton Beam Therapy for Localized Prostate Cancer

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

October 10, 2013

Primary Completion Date

June 1, 2028

Study Completion Date

June 1, 2028

Conditions
Stage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

RADIATION

Proton Beam Radiation Therapy

Undergo proton beam radiation therapy

OTHER

Quality-of-Life Assessment

Ancillary studies

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT01950351 - Hypofractionated Proton Beam Therapy for Localized Prostate Cancer | Biotech Hunter | Biotech Hunter